Literature DB >> 27497214

Prognostic value of imbalanced interhemispheric functional coordination in early therapeutic efficacy in major depressive disorder.

Zhenghua Hou1, Xiaopeng Song2, Wenhao Jiang1, Yingying Yue1, Yingying Yin1, Yuqun Zhang1, Yijun Liu3, Yonggui Yuan4.   

Abstract

This study aims to explore the early response of antidepressant therapy by measuring the voxel-mirrored homotopic connectivity (VMHC) in major depressive disorder (MDD). Eighty-two MDD patients [n=42 treatment-responsive depression (RD) and n=40 non-responding depression (NRD)] and n=50 normal controls (NC) underwent clinical measures and a magnetic resonance imaging scan, and the VMHC values were calculated. Receiver operating characteristic (ROC) curve analysis was applied to determine the capability of altered VMHC to distinguish NRD. The NRD showed significantly decreased VMHC in bilateral precuneus (PCU) and inferior temporal gyrus (ITG), and increased VMHC in middle frontal gyrus (MFG) and caudate nucleus as compared to RD. When compared with NC, the NRD exhibited reduced VMHC in bilateral cerebellum anterior lobe, thalamus and postcentral gyrus. Moreover, VHMC in medial frontal gyrus, postcentral gyrus and precentral gyrus were significantly decreased in RD. Correlation analysis showed that reduced VMHC in PCU was negatively correlated with the baseline HAMD score of the NRD group. The ROC curve indicated that the combined changes of the three regional VMHC (PCU, ITG and MFG) could effectively identify NRD. The current study suggests that interhemispheric asynchrony may represents a novel neural trait underlying the prediction of early therapeutic outcome in MDD.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Early treatment response; Functional magnetic resonance imaging; Major depressive disorder; Predictive marker; Voxel-mirrored homotopic connectivity

Mesh:

Substances:

Year:  2016        PMID: 27497214     DOI: 10.1016/j.pscychresns.2016.07.011

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  7 in total

1.  Brain structural changes associated with aberrant functional responses to the Valsalva maneuver in heart failure.

Authors:  Xiaopeng Song; Bhaswati Roy; Gregg C Fonarow; Mary A Woo; Rajesh Kumar
Journal:  J Neurosci Res       Date:  2018-09       Impact factor: 4.164

2.  Extreme male developmental trajectories of homotopic brain connectivity in autism.

Authors:  Nataliia Kozhemiako; Vasily Vakorin; Adonay S Nunes; Grace Iarocci; Urs Ribary; Sam M Doesburg
Journal:  Hum Brain Mapp       Date:  2018-10-11       Impact factor: 5.038

3.  Graph Theory Analysis of the Cortical Functional Network During Sleep in Patients With Depression.

Authors:  Yingjie Song; Kejie Wang; Yu Wei; Yongpeng Zhu; Jinfeng Wen; Yuxi Luo
Journal:  Front Physiol       Date:  2022-05-27       Impact factor: 4.755

4.  Connectome analysis of functional and structural hemispheric brain networks in major depressive disorder.

Authors:  Xueyan Jiang; Yuedi Shen; Jiashu Yao; Lei Zhang; Luoyi Xu; Rui Feng; Liqiang Cai; Jing Liu; Wei Chen; Jinhui Wang
Journal:  Transl Psychiatry       Date:  2019-04-12       Impact factor: 6.222

Review 5.  Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review.

Authors:  Katharine Dunlop; Aleksandr Talishinsky; Conor Liston
Journal:  Curr Psychiatry Rep       Date:  2019-08-13       Impact factor: 5.285

6.  Altered resting-state hippocampal and caudate functional networks in patients with obstructive sleep apnea.

Authors:  Xiaopeng Song; Bhaswati Roy; Daniel W Kang; Ravi S Aysola; Paul M Macey; Mary A Woo; Frisca L Yan-Go; Ronald M Harper; Rajesh Kumar
Journal:  Brain Behav       Date:  2018-05-10       Impact factor: 2.708

7.  Evidence of altered brain network centrality in patients with diabetic nephropathy and retinopathy: an fMRI study using a voxel-wise degree centrality approach.

Authors:  Yu Wang; Lei Jiang; Xiao-Yu Wang; Weizhe Chen; Yi Shao; Qin-Kai Chen; Jin-Lei Lv
Journal:  Ther Adv Endocrinol Metab       Date:  2019-07-27       Impact factor: 3.565

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.